Corona Therapy Develpment
Karachi (Web Desk) Dow University has entered a critical phase in the preparation of medicine for the treatment of corona.During the trial, the recovery of critically ill patients in the ICU was 60 percent.While the recovery of critically ill patients was 100 percent.
Corona's drug preparation has entered a critical phase, a successful clinical trial of a life-saving drug is underway in Corona.Doctors say that during the trial, the recovery of critically ill patients in the ICU was 60%.While that of critically ill Corona patients.Recovery from CIVIG was 100%.Work on CIVIG started in March under the direction of VC Muhammad Saeed Qureshi.Preparations were made by extracting antibodies from the plasma of healthy patients from CIVIG Corona.Dr. Shaukat Ali says that DRAP was supported for the clinical trial.
Vice Chancellor Prof Muhammad Saeed Qureshi termed.It as a very important development in the fight against code 19 and said that globulin was prepared from transparent antibodies obtained from the body of healthy patients and experts tested the prepared globulin and enamel.Safety trials were also successful.
Experts described the preparation of globulin in the Corona Crisis as a ray of hope.The team initially managed to collect blood samples in March 2020.Later, antibodies were collected from its plasma.
These antibodies were chemically isolated purified and subsequently synthesized by ultra-filtering techniques.Thus removing the remaining unwanted material from the antibodies, including certain viruses and bacteria.The final product is hyperimmunoglobulin.
0 Comments